1. Home
  2. Analysis
  3. Vyepti
  4. Chills

Vyepti and Chills - a phase IV clinical study of FDA data

Summary:

Chills is reported as a side effect among people who take Vyepti (eptinezumab-jjmr), especially for people who are female, 60+ old, also take Fioricet, and have Migraine.

The phase IV clinical study analyzes which people have Chills when taking Vyepti. It is created by eHealthMe based on reports of 4,895 people who have side effects when taking Vyepti from the FDA, and is updated regularly.

What is Vyepti?

Vyepti has active ingredients of eptinezumab-jjmr. eHealthMe is studying from 4,897 Vyepti users. Check the latest studies of Vyepti.

What is Chills?

Chills (felling of cold) is found to be associated with 2,567 drugs and 3,472 conditions by eHealthMe. Check the latest studies of Chills.

On Jul, 15, 2026

4,895 people reported to have side effects when taking Vyepti.
Among them, 24 people (0.49%) have Chills.

Could Vyepti cause Chills?

Among these 24 people:

What is the gender of people who have Chills when taking Vyepti? *

  • female: 95.65 %
  • male: 4.35 %

What is the age of people who have Chills when taking Vyepti? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.76 %
  • 30-39: 9.52 %
  • 40-49: 23.81 %
  • 50-59: 4.76 %
  • 60+: 57.14 %

What are other drugs people take besides Vyepti? *

  1. Fioricet: 5 people, 20.83%
  2. Zofran: 4 people, 16.67%
  3. Sodium Chloride: 3 people, 12.50%
  4. Epinephrine: 3 people, 12.50%
  5. Erythromycin: 3 people, 12.50%
  6. Invega: 3 people, 12.50%
  7. Klonopin: 3 people, 12.50%
  8. Lidocaine: 3 people, 12.50%
  9. Prolia: 3 people, 12.50%
  10. Acetaminophen: 3 people, 12.50%

What are other side effects people have besides Chills? *

  1. Nausea (feeling of having an urge to vomit): 10 people, 41.67%
  2. Migraine (headache): 9 people, 37.50%
  3. Fatigue (feeling of tiredness): 8 people, 33.33%
  4. Headache (pain in head): 7 people, 29.17%
  5. Fever: 5 people, 20.83%
  6. Hyperhidrosis (abnormally increased sweating): 5 people, 20.83%
  7. Drug Ineffective: 4 people, 16.67%
  8. Chest Pain: 4 people, 16.67%
  9. Hypotension (abnormally low blood pressure): 4 people, 16.67%
  10. Dyspnea (difficult or laboured breathing): 4 people, 16.67%

What are the existing conditions these people have? *

  1. Migraine (headache): 17 people, 70.83%
  2. Immunodeficiency Common Variable: 3 people, 12.50%
  3. Migraine With Aura (headache with vision weakness): 2 people, 8.33%
  4. Joint Pain: 1 person, 4.17%
  5. Headache (pain in head): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Vyepti and have Chills?

- Check whether Chills is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vyepti:

Chills treatments and more:

How severe was Chills and when was it recovered:

Expand to all the drugs that have ingredients of eptinezumab-jjmr:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vyepti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chills:

Browse all the conditions that are associated with Chills:

How the study uses the data?

The study uses data from the FDA. It is based on eptinezumab-jjmr (the active ingredients of Vyepti) and Vyepti (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.